U.S. anti‑aging market surges as consumers pursue medical and cosmetic skin solutions

The global anti‑aging market is projected to reach $78 billion in 2025, with the United States accounting for about 36 % of that value. U.S. sales are estimated at $21.6 billion last year and are expected to climb to roughly $23.1 billion this year, driven largely by skincare products, injectable treatments and a growing “longevity medicine” sector that includes whole‑body MRI scans, peptide therapies and regenerative procedures.

More than 29 million cosmetic and reconstructive procedures were performed in the United States in 2024, according to the American Society of Plastic Surgeons. Dermatologists are increasingly using advanced imaging devices such as VISIA and Oura to map skin health, identify sun‑damage, and tailor treatment plans that may combine topical regimens, laser therapy, fillers or surgical options. As Dr. Missy Clifton warned, “the sun can cause a lot of different problems, everything from permanent freckles to wrinkles to enlarged pores,” and skin‑cancer rates continue to rise.

The World Health Organization defines healthy aging as maintaining functional ability and independence rather than merely preserving appearance, underscoring the shift toward health‑focused anti‑aging strategies alongside cosmetic demand.